Acute kidney injury and acute kidney recovery following Transcatheter Aortic Valve Replacement

Marilou Peillex, Benjamin Marchandot, Kensuke Matsushita, Eric Prinz, Sebastien Hess, Antje Reydel, Marion Kibler, Adrien Carmona, Antonin Trimaille, Joe Heger, Hélène Petit-Eisenmann, Annie Trinh, Laurence Jesel, Patrick Ohlmann and Olivier Morel

PLOS ONE, 2021, vol. 16, issue 8, 1-14

Abstract: Background: Acute kidney injury (AKI) is associated with a dismal prognosis in Transcatheter Aortic Valve replacement (TAVR). Acute kidney recovery (AKR), a phenomenon reverse to AKI has recently been associated with better outcomes. Methods: Between November 2012 to May 2018, we explored consecutive patients referred to our Heart Valve Center for TAVR. AKI was defined according to the VARC-2 definition. Mirroring the VARC-2 definition of AKI, AKR was defined as a decrease in serum creatinine (≥50%) or ≥25% improvement in GFR up to 72 hours after TAVR. Results: AKI and AKR were respectively observed in 8.3 and 15.7% of the 574 patients included. AKI and AKR patients were associated to more advanced kidney disease at baseline. At a median follow-up of 608 days (range 355–893), AKI and AKR patients experienced an increased cardiovascular mortality compared to unchanged renal function patients (14.6% and 17.8% respectively, vs. 8.1%, CI 95%, p

Date: 2021
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0255806 (text/html)
https://journals.plos.org/plosone/article/file?id= ... 55806&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pone00:0255806

DOI: 10.1371/journal.pone.0255806

Access Statistics for this article

More articles in PLOS ONE from Public Library of Science
Bibliographic data for series maintained by plosone ().